SMD Rise PCL
SMD Rise PCL operates in the medical equipment, supplies, and distribution sector, providing healthcare services and equipment to the market.
Business. SMD Rise PCL (SMD100M.BK) is a healthcare services and equipment company primarily engaged in the medical equipment, supplies, and distribution industry. The firm operates on a product-sale revenue model, focusing on the provision of medical devices and related consumables. Headquartered in Thailand, the company is listed on the Stock Exchange of Thailand (SET). Specific details regarding operating segments and geographic revenue breakdowns are not disclosed in the available data.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
SMD Rise PCL (SMD100M.BK) is a healthcare services and equipment company primarily engaged in the medical equipment, supplies, and distribution industry. The firm operates on a product-sale revenue model, focusing on the provision of medical devices and related consumables. Headquartered in Thailand, the company is listed on the Stock Exchange of Thailand (SET). Specific details regarding operating segments and geographic revenue breakdowns are not disclosed in the available data.
SMD Rise PCL exhibits a strong liquidity position, with a current ratio of 7.6, indicating the company can easily cover its short-term liabilities with its current assets. The company holds cash and equivalents of 230.7 million THB, which is significantly higher than its total liabilities of 179.3 million THB, further reinforcing its liquidity buffer. However, the company reported negative operating cash flow of -50.8 million THB and free cash flow of -9.9 million THB, suggesting operational inefficiencies or capital outflows.
Profitability metrics are weak, with a return on equity (ROE) of -1.24% and a return on assets (ROA) of -1.03%, both below the typical thresholds for healthy performance in the healthcare equipment and services industry. The company reported a net loss of 10.5 million THB and an operating loss of 10.2 million THB, indicating a challenging operating environment. Gross profit of 43.7 million THB on total revenue of 139.3 million THB suggests margin pressures, with a gross margin of approximately 31.4%.
The company's revenue is not segmented by geographic region or product line in the available data, making it difficult to assess geographic or product concentration risks. However, the lack of segment data implies a potentially undiversified revenue base, which could expose the company to regional or product-specific downturns.
Looking ahead, the company's growth trajectory is uncertain, as no specific revenue growth or decline figures are provided for the current or next fiscal year. The negative operating and free cash flows suggest that the company may need to rely on external financing or asset sales to fund operations or expansion. The capital expenditure of -7.2 million THB indicates some level of investment in infrastructure or equipment, but the negative value suggests a net outflow.
Risk factors for SMD Rise PCL include the company's negative net income and operating income, which could affect its ability to service debt or fund operations. The risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. However, the company's negative cash flows and operating losses could increase financial risk in the future if not addressed.
Recent events or filings do not appear to have significantly impacted the company's financial position, as no specific events are disclosed in the available data. The company's financial statements do not indicate any recent material changes in operations or strategy.
- SMD Rise PCL has a strong liquidity position with a current ratio of 7.6 and significant cash reserves.
- The company is currently unprofitable, with a net loss of 10.5 million THB and an operating loss of 10.2 million THB.
- Negative operating and free cash flows suggest operational inefficiencies or capital outflows.
- The company's financial risk is currently low, but its negative cash flows and operating losses could increase risk in the future.
- The lack of segment data implies a potentially undiversified revenue base, which could expose the company to regional or product-specific downturns.
Bull / Bear case
Generated · model-assistedFree cash flow surged 66.2% year-over-year to THB 42.6 million, demonstrating significant improvement in cash generation capabilities.
Cash conversion ratio of 4.85 ranks as best-in-class, significantly outperforming the cohort median of 0.84.
Debt-to-equity ratio of 0.06 is well below the cohort median of 0.20, indicating a conservative capital structure.
Revenue grew 14.8% year-over-year to THB 910.2 million, showing top-line expansion despite profitability challenges.
Dilution and liquidity risks are assessed as low, suggesting stable shareholder equity and adequate market trading conditions.
Return on equity of -1.24% underperforms the cohort median of 1.42%, indicating inefficient use of shareholder capital.
Credit risk is flagged as high, posing a significant threat to the company's financial stability and borrowing costs.
Four-year net income CAGR of -57.3% highlights a persistent and severe long-term decline in earnings power.
In focus — financials by report
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- SMD Rise PCL Market data — financials · 2026-05-29